Menu

布地奈德缓释胶囊的作用与功效

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

It is a new type of GCs that acts locally on the intestine and has low systemic bioavailability after first-pass metabolism by the liver. It is similar to traditional GCs in inducing the remission of mild to moderately active ileocolonic CD, but causes significantly fewer GCs-related adverse reactions than traditional GCs, and has higher safety. The European CD and Colitis Organization (ECCO) consensus meeting recommended that patients with mild or moderate ileocolonic CD can be treated with budesonide 9 mg/d for 8 to 16 weeks, and then reduce the dose by 3 mg/d every 2 to 4 weeks.

The role and efficacy of budesonide sustained-release capsules: Budesonide is an ileal controlled-release hormone preparation. Its biggest advantage is that it significantly reduces the inhibitory effect of traditional hormone preparations on the adrenal cortex and reduces the side effects of traditional hormone use. However, a randomized placebo-controlled study showed that although budesonide can improve the effect of placebo in inducing remission in active Crohn's disease, it does not exceed placebo. Because of its few side effects, it is generally recommended in the literature for ileum and right colon lesions.

(≥5%): Dizziness, respiratory tract infection, nausea, abdominal pain, indigestion, flatulence, headache, back pain, vomiting, fatigue, pain. During the medication period, patients must not increase or decrease the dose of the drug by themselves. Budesonide sustained-release capsules will not improve the therapeutic effect just because the dose of the drug is increased, so do not use the drug blindly.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended hot articles:

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。